Federal Court Orders Johnson & Johnson Unit to Pay $1.64 Billion in Landmark Whistleblower HIV Drug Case
Trenton, New Jersey – A federal judge has mandated Johnson & Johnson’s Janssen Pharmaceuticals unit to pay a hefty $1.64 billion for allegedly marketing two HIV medications, Prezista and Intelence, for unapproved uses. This order followed a recent jury verdict that found the company liable under whistleblower lawsuit claims. U.S. District Judge Zahid Quraishi ruled that Janssen violated the federal False Claims Act, leading to a direct $360 million fine. The company also faces civil fines amounting to $1.28 billion, which calculates to $8,000 for each of the 159,574 false claims submitted to government programs … Read more